ROX指数预测接受高流量鼻导管氧疗的内科ICU患者拔管后48小时再插管
该研究回顾性分析三星医疗中心前瞻性入组的观察性ICU队列中726例拔管后接受高流量鼻导管氧疗的机械通气成人,评估呼吸频率-氧合(ROX)指数预测48小时内再插管的判别能力。再插管发生率为15.4%,总体ROX判别能力有限,但按拔管当日PaO2/FiO2分层后判别能力随低氧血症加重而升高。
要点
- 拔管后48小时内再插管发生率为112/726(15.4%)。
- 总体ROX判别能力有限,AUROC在2小时为0.681、6小时为0.681、12小时为0.677、18小时为0.730、24小时为0.614。
- PaO2/FiO2<200亚组聚类AUROC为0.762,ROX或可作为该组拔管后风险分层的辅助工具。
核心结论
- ROX指数对接受拔管后高流量鼻导管氧疗患者预测再插管的判别能力有限,但判别能力随低氧血症严重程度而变化,ROX或可作为PaO2/FiO2<200患者拔管后风险分层的辅助工具。
研究设计与样本
- 回顾性分析三星医疗中心(韩国首尔)前瞻性入组的观察性ICU队列数据。
- 在1881例机械通气成人中,分析726例拔管后接受高流量鼻导管氧疗的拔管事件。
- 主要结局为拔管后48小时内再插管,拔管后24小时内每小时计算ROX。
- 采用受试者工作特征曲线下面积(AUROC)和聚类受试者工作特征曲线方法评估判别能力,按拔管当日PaO2/FiO2分层。
主要发现
- 726例拔管事件中112例发生再插管(15.4%)。
- 总体ROX判别能力有限:AUROC在2小时为0.681、6小时为0.681、12小时为0.677、18小时为0.730、24小时为0.614。
- 聚类AUROC随低氧血症严重程度变化:PaO2/FiO2≥300组为0.545(n=118),PaO2/FiO2 200-<300组为0.684(n=460),PaO2/FiO2<200组为0.762(n=148)。
- 在PaO2/FiO2<200组中,偶数小时推导的ROX阈值在奇数小时表现相似:纳入阈值4.21和6.60,平衡阈值9.70(Youden),排除阈值12.50和16.96。
- 从ROX<9.7至再插管的中位时间为14.1小时。
关键数值与推荐
- PaO2/FiO2≥300组聚类AUROC为0.545(n=118)。
- PaO2/FiO2 200-<300组聚类AUROC为0.684(n=460)。
- PaO2/FiO2<200组聚类AUROC为0.762(n=148)。
- PaO2/FiO2<200组偶数小时推导的ROX阈值:纳入阈值4.21和6.60,平衡阈值9.70(Youden),排除阈值12.50和16.96。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The respiratory rate-oxygenation (ROX) index predicts HFNC failure in pneumonia with hypoxemic respiratory failure, but its utility in the post-extubation HFNC setting remains unclear. METHODS: We retrospectively analysed data from a prospectively enrolled observational ICU cohort at Samsung Medical Center (Seoul, Korea). Among 1881 mechanically ventilated adults, we analysed 726 extubation episodes managed with post-extubation HFNC. The primary outcome was reintubation within 48 h. ROX was calculated hourly for 24 h after extubation. Diagnostic discrimination was assessed using area under the receiver operating characteristic curve (AUROC) and clustered receiver operating characteristic methods, stratified by PaO2/FiO2 on the day of extubation. RESULTS: Reintubation occurred in 112/726 extubation episodes (15.4%). Overall, ROX demonstrated limited discrimination (AUROC 0.681 at 2 h, 0.681 at 6 h, 0.677 at 12 h, 0.730 at 18 h, and 0.614 at 24 h). Clustered AUROC varied according to hypoxaemia severity: 0.545 (PaO2/FiO2 ≥ 300; n = 118), 0.684 (PaO2/FiO2 200-< 300; n = 460), and 0.762 (PaO2/FiO2 < 200; n = 148). In PaO2/FiO2 < 200, even-hour-derived ROX thresholds performed similarly in odd hours: rule-in 4.21 and 6.60, balanced 9.70 (Youden), and rule-out 12.50 and 16.96. Median time from ROX < 9.7 to reintubation was 14.1 h. CONCLUSION: ROX demonstrated limited discriminative performance for predicting reintubation after extubation in patients receiving post-extubation HFNC. However, discrimination varied by hypoxaemia severity, and ROX may serve as an adjunct for post-extubation risk stratification in patients with PaO2/FiO2 < 200.
引用
- Choe J, Jeong BH, Jeon K, et al. ROX Index for Prediction of 48-h Reintubation After Extubation in Medical ICU Patients Receiving High-Flow Nasal Cannula. Respirology. 2026. PMID: 43023541. doi:10.1002/resp.70347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。